Abstract | OBJECTIVE: METHODS: Thirteen prepubertal children ages 4 to 11 years completed this study. Inclusion criteria included T1DM ≥6 months, glycosylated hemoglobin (HbA1C) 6.9 to 10%, blood glucose (BG) levels in adequate control for 1 week prior to study start, multiple daily injections (MDI) with insulin glargine or determir once daily and aspart or lispro premeal. If fasting BG was 70 to 180 mg/dL, subjects received insulin glulisine alternating with aspart prior to a prescribed breakfast with a fixed amount of carbohydrate (45, 60, or 75 g) for 20 days. Postprandial BG values were obtained at 2 and 4 hours. RESULTS: Mean baseline BG values for insulin glulisine (136.4 ± 15.7 mg/dL; mean ± SD) and aspart (133.4 ± 14.7 mg/dL) were similar (P = .34). Mean increase in 2-hour postprandial BG was higher in glulisine (+113.5 ± 65.2 mg/dL) than aspart (+98.6 ± 66.9 mg/dL), (P = .01). BG remained higher at 4 hours (glulisine: 141.9 ± 36.5 mg/dL, aspart: 129.0 ± 37.0 mg/dL) (P = .04). Although statistically insignificant, more hypoglycemic events occurred at 2- and 4-hours postprandial with insulin aspart. CONCLUSION:
Insulin aspart appears to be more effective than insulin glulisine in controlling 2- and 4-hour postprandial BG excursions in prepubertal children with T1DM.
|
Authors | Ayse Pinar Cemeroglu, Lora Kleis, Andrew Wood, Chad Parkes, Michael A Wood, Alan T Davis |
Journal | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
(Endocr Pract)
2013 Jul-Aug
Vol. 19
Issue 4
Pg. 614-9
ISSN: 1934-2403 [Electronic] United States |
PMID | 23425652
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- Hypoglycemic Agents
- Insulin
- insulin glulisine
- Insulin Aspart
|
Topics |
- Blood Glucose
(drug effects)
- Breakfast
- Child
- Child, Preschool
- Drug Administration Schedule
- Female
- Humans
- Hypoglycemic Agents
(administration & dosage, therapeutic use)
- Injections
- Insulin
(administration & dosage, analogs & derivatives, therapeutic use)
- Insulin Aspart
(administration & dosage, therapeutic use)
- Male
- Postprandial Period
(drug effects)
|